GRIT BIOTECHNOLOGY Trademark

Trademark Overview


On Thursday, July 7, 2022, a trademark application was filed for GRIT BIOTECHNOLOGY with the United States Patent and Trademark Office. The USPTO has given the GRIT BIOTECHNOLOGY trademark a serial number of 97492270. The federal status of this trademark filing is OPPOSITION PENDING as of Tuesday, November 7, 2023. This trademark is owned by Suzhou GRIT BIOTECHNOLOGY Co., Ltd.. The GRIT BIOTECHNOLOGY trademark is filed in the Advertising, Business and Retail Services category with the following description:

Retail distributorship and wholesale distributorship services featuring pharmaceutical preparations, namely, biological preparations for developing T-cell based immunotherapy by building a series of proprietary tumor infiltrating lymphocyte; Retail distributorship and wholesale distributorship services featuring pharmaceutical preparations, namely, medical cell function activating drugs for developing T-cell based immunotherapy by building a series of proprietary tumor infiltrating lymphocyte; Retail distributorship and wholesale distributorship services featuring pharmaceutical preparations, namely, biological agents for treating cancer, namely, for treatment of solid tumor cancers by tumor infiltrating lymphocyte (TIL) therapy; Retail distributorship and wholesale distributorship services featuring pharmaceutical preparations, namely, tumor suppressors for treating cancer, namely, for treatment of solid tumor cancers by TIL therapy
grit biotechnology

General Information


Serial Number97492270
Word MarkGRIT BIOTECHNOLOGY
Filing DateThursday, July 7, 2022
Status774 - OPPOSITION PENDING
Status DateTuesday, November 7, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 11, 2023

Trademark Statements


Goods and ServicesRetail distributorship and wholesale distributorship services featuring pharmaceutical preparations, namely, biological preparations for developing T-cell based immunotherapy by building a series of proprietary tumor infiltrating lymphocyte; Retail distributorship and wholesale distributorship services featuring pharmaceutical preparations, namely, medical cell function activating drugs for developing T-cell based immunotherapy by building a series of proprietary tumor infiltrating lymphocyte; Retail distributorship and wholesale distributorship services featuring pharmaceutical preparations, namely, biological agents for treating cancer, namely, for treatment of solid tumor cancers by tumor infiltrating lymphocyte (TIL) therapy; Retail distributorship and wholesale distributorship services featuring pharmaceutical preparations, namely, tumor suppressors for treating cancer, namely, for treatment of solid tumor cancers by TIL therapy
Disclaimer with Predetermined Text"BIOTECHNOLOGY"

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, June 7, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSuzhou GRIT BIOTECHNOLOGY Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSuzhou 215121
CN

Party NameSuzhou GRIT BIOTECHNOLOGY Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSuzhou 215121
CN

Trademark Events


Event DateEvent Description
Tuesday, November 7, 2023OPPOSITION INSTITUTED NO. 999999
Friday, August 4, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, July 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2023PUBLISHED FOR OPPOSITION
Wednesday, June 21, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 7, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, June 7, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 7, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, June 7, 2023EXAMINERS AMENDMENT -WRITTEN
Friday, May 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 12, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 27, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 27, 2023NON-FINAL ACTION E-MAILED
Thursday, April 27, 2023NON-FINAL ACTION WRITTEN
Friday, April 21, 2023ASSIGNED TO EXAMINER
Tuesday, July 12, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 11, 2022NEW APPLICATION ENTERED